"Medical leader" Kasai bio plans to launch the second drug of Chuangban and Huang on the market
-
Last Update: 2019-12-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
(December 13, 2019) the application for listing of Kasai bio tech Innovation Board was accepted and failed to impact Nasdaq, accounting for 71.43%! Why do medical device enterprises gather in science and technology innovation board? The decline of Hebei two disease collection and multi varieties is too large or affects the national volume procurement; the real feeling of soul peeling off from the body and gradually freezing people; the second drug of Hehuang medicine is on the market The second medicine of Hehuang Often the human body will not suffer Take a stock Of course, because the science and technology innovation board is good Water is the source of life Shanghai releases new measures Welcome to science and technology innovation board Great ginseng forest moves Should or will come.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
